|Bid||39.00 x 1800|
|Ask||39.01 x 1200|
|Day's range||38.71 - 39.03|
|52-week range||33.26 - 42.68|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||13.41|
|Earnings date||01 Feb 2017 - 06 Feb 2017|
|Forward dividend & yield||2.17 (5.41%)|
|Ex-dividend date||20 May 2021|
|1y target est||48.04|
Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.
Dr. Stella Safo, NYC-based HIV Primary Care Physician, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.
GSK vs. NVO: Which Stock Is the Better Value Option?